Recognized as the industry’s leading forum for cell therapy analytical, quality control, assay, and CMC professionals, the 7th Cell Therapy Analytical Development Summit, returns to Boston to provide the expertise needed to prepare your teams for clinical and commercial readiness. Hear directly 80+ experts from Takeda, Arsenal Bio, Bayer, Genentech, Adicet Bio, Quell Therapeutics, and the National Institute of Health, as they share proven strategies, innovative technologies and best-in-class approaches to enhance your product safety and quality, ahead of regulatory approval.

Now combined with the previously separate, Cell Therapy Potency Assay Summit, this meeting provides you with an even more comprehensive agenda, covering the full landscape of analytical development, across early- and late-stage assay development tracks. Join us this December to fast-track the next era of safe, potent and robust cell therapies to market!

For more information, please visit https://ter.li/9uagdj